Skip to main content
Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
1.660
0.00 (0.00%)
At close: Nov 13, 2026, 4:00 PM EST
1.650
-0.010 (-0.60%)
After-hours: Nov 13, 2026, 7:30 PM EST

Xenetic Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2.962.982.52.541.711.16
Revenue Growth
3.50%19.04%-1.56%48.80%47.06%165.64%
Gross Profit
2.962.982.52.541.711.16
Selling, General & Admin
4.292.753.423.563.653.74
Research & Development
2.513.073.293.494.773.16
Operating Expenses
6.85.816.77.068.426.91
Operating Income
-3.84-2.83-4.2-4.52-6.72-5.75
Interest & Investment Income
0.170.150.250.360.170.1
Other Non Operating Income (Expenses)
00.01-0.010.03-00
EBT Excluding Unusual Items
-3.66-2.68-3.96-4.13-6.55-5.65
Pretax Income
-3.66-2.68-3.96-4.13-6.55-5.65
Net Income
-3.66-2.68-3.96-4.13-6.55-5.65
Net Income to Common
-3.66-2.68-3.96-4.13-6.55-5.65
Net Income Growth
------
Shares Outstanding (Basic)
222211
Shares Outstanding (Diluted)
222211
Shares Change
47.67%10.40%0.86%7.44%38.38%60.81%
EPS (Basic)
-1.61-1.58-2.57-2.71-4.61-5.49
EPS (Diluted)
-1.61-1.58-2.57-2.71-4.61-5.49
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-2.32-2.29-2.82-4.11-4.65-4.74
Free Cash Flow Per Share
-1.02-1.34-1.83-2.69-3.27-4.61
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-129.63%-95.23%-168.16%-177.78%-393.57%-495.12%
Profit Margin
-123.71%-90.07%-158.39%-162.78%-383.87%-486.36%
Free Cash Flow Margin
-78.29%-76.83%-112.69%-161.98%-272.23%-408.21%
EBITDA
------5.75
D&A For EBITDA
-----0
EBIT
-3.84-2.83-4.2-4.52-6.72-5.75
EBIT Margin
-129.63%-95.23%-168.16%-177.78%--
Revenue as Reported
2.962.982.52.541.711.16
SEC Filings: 10-K · 10-Q